6个月至5岁儿童的视力筛查:美国预防服务工作组证据报告与系统综述
本系统综述纳入40项研究(N=34 709),评估6个月至5岁儿童弱视、其危险因素及屈光不正的筛查与治疗证据。无随机对照试验比较筛查与不筛查,多数筛查试验阳性似然比在5至10之间,低患病率(<10%)时假阳性率高(通常>75%)。遮盖治疗可改善弱视眼视力,但直接评价筛查有效性的证据有限。
要点
- 无随机对照试验直接比较筛查与不筛查,不能确定学龄前视力筛查是否优于不筛查。
- 多数筛查试验阳性似然比在5至10之间,联合临床检查时多大于10;低患病率(<10%)下假阳性率通常>75%。
- 遮盖治疗可改善弱视眼视力,但直接评价筛查有效性的证据有限。
核心结论
- 直接评价筛查有效性的研究有限,不能确定学龄前儿童视力筛查是否优于不筛查。
- 间接证据支持多种筛查试验用于识别视力问题风险较高的学龄前儿童,并支持某些治疗可改善视力结局。
研究设计与样本
- 系统综述纳入40项研究(N=34 709),其中34项评价试验准确性。
- 检索MEDLINE、Cochrane Library、CINAHL和试验注册库至2016年6月,文献监测至2017年6月7日。
- 纳入英文随机对照试验或前瞻性队列研究(评价筛查)、试验准确性研究、治疗与无活性对照的随机对照试验、评估危害的队列或病例对照研究。
- 因临床和方法学异质性未进行定量合并。
主要发现
- 无随机对照试验比较筛查与不筛查,无研究评价学校表现、功能或生活质量。
- 多数试验准确性研究中,弱视危险因素或非弱视性屈光不正的阳性似然比在5至10之间,联合临床检查时多大于10。
- 视力异常患病率低(<10%)的研究显示高假阳性率(通常>75%)。
- 在弱视危险因素儿童中,经眼镜预治疗者遮盖治疗5至12周后弱视眼视力平均改善小于1行(2项随机对照试验,240名参与者);遮盖治疗组较未遮盖组更多儿童视力改善至少2行(45% vs 21%;P=0.003;1项随机对照试验,180名参与者)。
- 未经眼镜预治疗者,遮盖加眼镜治疗1年后视力改善约1行(0.11 logMAR [95%CI,0.05-0.17];1项随机对照试验,177名参与者);单独眼镜治疗1年后视力改善小于1行(0.08 logMAR [95%CI,0.02-0.15];1项随机对照试验,177名参与者)。
关键数值与推荐
- 多数筛查试验阳性似然比在5至10之间,联合临床检查时多大于10。
- 低患病率(<10%)下假阳性率通常>75%。
- 遮盖治疗组45% vs 未遮盖组21%的儿童视力改善至少2行(P=0.003)。
- 遮盖加眼镜治疗1年后logMAR改善0.11(95%CI,0.05-0.17);单独眼镜治疗改善0.08(95%CI,0.02-0.15)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 无随机对照试验比较筛查与不筛查。
- 无研究评价学校表现、功能或生活质量。
- 直接评估更早或更密集筛查的研究受高失访率限制。
- 因临床和方法学异质性未进行定量合并。
- 3岁以下儿童因无法配合可能限制某些试验的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Preschool vision screening could allow detection and treatment of vision abnormalities during a critical developmental stage, preserving function and quality of life. OBJECTIVE: To review the evidence on screening for and treatment of amblyopia, its risk factors, and refractive error in children aged 6 months to 5 years to inform the US Preventive Services Task Force. DATA SOURCES: MEDLINE, Cochrane Library, CINAHL, and trial registries through June 2016; references; and experts, with surveillance of the literature through June 7, 2017. STUDY SELECTION: English-language randomized clinical trials (RCTs) or prospective cohort studies that evaluated screening, studies evaluating test accuracy, RCTs of treatment vs inactive controls, and cohort studies or case-control studies assessing harms. DATA EXTRACTION AND SYNTHESIS: Dual review of abstracts, full-text articles, and study quality; qualitative synthesis of findings. Studies were not quantitatively pooled because of clinical and methodological heterogeneity. MAIN OUTCOMES AND MEASURES: Visual acuity, amblyopia, school performance, functioning, quality of life, test accuracy, testability, and harms. RESULTS: Forty studies were included (N = 34 709); 34 evaluated test accuracy. No RCTs compared screening with no screening, and no studies evaluated school performance, function, or quality of life. Studies directly assessing earlier or more intensive screening were limited by high attrition. Positive likelihood ratios were between 5 and 10 for amblyopia risk factors or nonamblyogenic refractive error in most studies of test accuracy and were greater than 10 in most studies evaluating combinations of clinical tests. Inability to cooperate may limit use of some tests in children younger than 3 years. Studies with low prevalence (<10%) of vision abnormalities showed high false-positive rates (usually >75%). Among children with amblyopia risk factors (eg, strabismus or anisometropia), patching improved visual acuity of the amblyopic eye by a mean of less than 1 line on a standard chart after 5 to 12 weeks for children pretreated with glasses (2 RCTs, 240 participants); more children treated with patching than with no patching experienced improvement of at least 2 lines (45% vs 21%; P = .003; 1 RCT, 180 participants). Patching plus glasses improved visual acuity by about 1 line after 1 year (0.11 logMAR [95% CI, 0.05-0.17]) for children not pretreated with glasses (1 RCT, 177 participants). Glasses alone improved visual acuity by less than 1 line after 1 year (0.08 logMAR [95% CI, 0.02-0.15], 1 RCT, 177 participants). CONCLUSIONS AND RELEVANCE: Studies directly evaluating the effectiveness of screening were limited and do not establish whether vision screening in preschool children is better than no screening. Indirect evidence supports the utility of multiple screening tests for identifying preschool children at higher risk for vision problems and the effectiveness of some treatments for improving visual acuity outcomes.
引用
- Jonas DE, Amick HR, Wallace IF, et al. Vision Screening in Children Aged 6 Months to 5 Years: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2017. PMID: 28873167. doi:10.1001/jama.2017.9900
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。